TW222583B - - Google Patents
Info
- Publication number
- TW222583B TW222583B TW082100297A TW82100297A TW222583B TW 222583 B TW222583 B TW 222583B TW 082100297 A TW082100297 A TW 082100297A TW 82100297 A TW82100297 A TW 82100297A TW 222583 B TW222583 B TW 222583B
- Authority
- TW
- Taiwan
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82349592A | 1992-01-21 | 1992-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW222583B true TW222583B (US06534493-20030318-C00130.png) | 1994-04-21 |
Family
ID=25238929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW082100297A TW222583B (US06534493-20030318-C00130.png) | 1992-01-21 | 1993-01-18 |
Country Status (10)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5122522A (en) * | 1989-06-21 | 1992-06-16 | The Trustees Of The University Of Pennsylvania | Treatment and control of ocular development |
| CA2276287C (en) * | 1997-01-06 | 2007-10-30 | Klaus Trier Aps | Screening method for compounds active in treating myopia and hypermetropia |
| US9827250B2 (en) | 2012-07-31 | 2017-11-28 | Johnson & Johnson Vision Care, Inc. | Lens incorporating myopia control optics and muscarinic agents |
| JP6784407B2 (ja) * | 2015-04-24 | 2020-11-11 | 学校法人慶應義塾 | 近視予防剤及び近視進行抑制剤 |
| GB201510010D0 (en) | 2015-06-09 | 2015-07-22 | King S College London | PDD and BPD compounds |
| GB201514928D0 (en) | 2015-08-21 | 2015-10-07 | King S College London | PDD compounds |
| US20180339985A1 (en) | 2015-08-21 | 2018-11-29 | Femtogenix Limited | Pdd compounds |
| US10845622B2 (en) | 2015-09-15 | 2020-11-24 | Largan Medical Co., Ltd. | Multifocal contact lens and contact lens product |
| CN110320676A (zh) | 2015-09-15 | 2019-10-11 | 星欧光学股份有限公司 | 隐形眼镜产品 |
| CN115414357B (zh) * | 2022-08-30 | 2023-09-22 | 天津医科大学眼科医院 | 一种酰胺类化合物在制备防治近视的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1212742B (it) * | 1983-05-17 | 1989-11-30 | Dompe Farmaceutici Spa | Derivati dibenzo [1,4]diazepinonici pirido [1,4] benzodiazepinonici,pirido [1,5] benzodiazepinonici e loro attivita' farmacologica |
| ATE203666T1 (de) * | 1989-06-21 | 2001-08-15 | Univ Pennsylvania | Verwendung eines muskarinantagonists zur herstellung eines medikaments für die behandlung und regulierung der augenentwicklung |
-
1993
- 1993-01-12 WO PCT/US1993/000241 patent/WO1993013777A1/en not_active Application Discontinuation
- 1993-01-14 EP EP93300208A patent/EP0556947A1/en not_active Withdrawn
- 1993-01-15 IL IL104409A patent/IL104409A0/xx unknown
- 1993-01-18 TW TW082100297A patent/TW222583B/zh active
- 1993-01-18 JP JP5005813A patent/JPH0742231B2/ja not_active Expired - Lifetime
- 1993-01-18 CA CA002087510A patent/CA2087510A1/en not_active Abandoned
- 1993-01-20 MX MX9300250A patent/MX9300250A/es unknown
- 1993-01-20 CN CN93100697A patent/CN1074606A/zh active Pending
- 1993-01-20 ZA ZA1993374A patent/ZA93384B/xx unknown
- 1993-01-20 AU AU31923/93A patent/AU3192393A/en not_active Abandoned
- 1993-01-20 ZA ZA93374A patent/ZA93374B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA93374B (en) | 1993-08-23 |
| MX9300250A (es) | 1993-07-01 |
| CN1074606A (zh) | 1993-07-28 |
| JPH0742231B2 (ja) | 1995-05-10 |
| ZA93384B (en) | 1993-08-23 |
| AU3192393A (en) | 1993-07-22 |
| IL104409A0 (en) | 1993-05-13 |
| EP0556947A1 (en) | 1993-08-25 |
| CA2087510A1 (en) | 1993-07-22 |
| WO1993013777A1 (en) | 1993-07-22 |
| JPH06206820A (ja) | 1994-07-26 |
